AAIC 2025 Abstract
Characterization of MRI‐derived atrophy subtypes using post‐mortem MRI and neuropathological markers in Alzheimer's disease
By Ismael Luis Calandri, Laura E. Jonkman, Sophie E Mastenbroek, Show 4 more authorsRik Ossenkoppele
Study in peopleBiomarkers
Abstract
Background: Alzheimer's disease (AD) exhibits diverse neurodegeneration patterns, highlighting the need for detailed atrophy mapping to improve early diagnosis and monitoring.
